Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. (SYRS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SYRS · as of Jun 9, 2026
Key Statistics
Explore Syros Pharmaceuticals, Inc. Data
syrs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 44.4%
The SYRS analyst consensus is Hold, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $16.67, representing +8334900.00% upside from the current price of $0.00.
Competitors & Peers
syrs competitorsSYRS
COEP
DRMA
KTTA
NKGN
NUVOStock Performance
Full HistoryAbout Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. operates as a biopharmaceutical firm primarily focused on discovering and developing novel therapeutic solutions for various cancers and monogenic (single-gene) diseases. A…
what is syros pharmaceuticals, inc. · syrs stock overview · syros pharmaceuticals, inc. company profile · who is syros pharmaceuticals, inc. ceo · syrs OTC · syros pharmaceuticals, inc. headquarters · syros pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Syros Pharmaceuticals, Inc. (SYRS) is a Healthcare company in the Biotechnology industry, listed on OTC since Jun 30, 2016. As of the latest trading session, SYRS stock price is $0.00, with a market capitalization of $5,366. The stock has returned -99.20% over the past 12 months and -42.86% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Syros Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $16.67. In fiscal year 2023, Syros Pharmaceuticals, Inc. reported revenue of $9.9M and net income of -$164.6M. For detailed data — including Syros Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Syros Pharmaceuticals, Inc. (SYRS) stock price is $0.00. The stock is traded on OTC under the ticker symbol SYRS. The 52-week range is $0.00 – $0.04.